CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 166 enrolled
Drug / intervention
argon plasma coagulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04366583
NCT04366583Phase 4Completed
CompareCT.gov

Comparison of Hemostatic Efficacy for Argon Plasma Coagulation vs Hemoclipping Following Distilled Water Injection in Treating High-risk Bleeding Ulcers

Kaohsiung Veterans General Hospital.·interventional·Posted Apr 29, 2020·Updated Dec 23, 2020

In Brief

A Phase 4 clinical trial evaluating argon plasma coagulation and hemoclipping for Bleeding Peptic Ulcer. Completed, enrolled 166 participants across 1 site.

Detailed Summary

Endoscopic treatment is recommended for initial hemostasis in nonvariceal upper gastrointestinal bleeding. However, the additional hemostatic efficacy of argon plasma coagulation (APC) has not been widely investigated. We designed a randomized trial comparing APC plus injection therapy vs hemoclipping plus injection therapy for peptic ulcer bleeding.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBleeding Peptic Ulcer
CountriesTaiwan
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 29, 2020
Enrollment StartFeb 9, 2012
Primary CompletionFeb 28, 2016
Study CompletionApr 25, 2016
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 6.2 years ago

Interventions

argon plasma coagulationdevice

Olympus electrosurgical unit/argon plasma coagulation unit (PSD-60/Endoplasma, Olympus Corp., Tokyo, Japan)

hemoclippingdevice

clipping device (Olympus HX 110/610, Olympus Corp., Tokyo, Japan)